Postoperative Complications After Appendectomy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03119740 |
Recruitment Status :
Completed
First Posted : April 19, 2017
Last Update Posted : April 19, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Appendicitis |
Background: Acute appendicitis is a common emergency in general surgery. The frequency of complications after appendectomy is about 9% [9]. The predictive value of CRP as an indicator of postoperative complications has been addressed in a small number of studies. The aim of the present retrospective analysis was to determine whether postoperative CRP levels are a reliable predictor of postoperative complications.
Methods: This retrospective single-center cohort study comprised 744 patients who had undergone open or laparoscopic appendectomy for clinically suspected appendicitis between 1 January 2011 and 31 December 2015 at the department of general and visceral surgery, Kepler University Hospital in Linz, Austria. Demographic data, the surgical technique, postoperative complications, histopathological findings, postoperative white blood counts, and C-reactive protein levels were evaluated.
Study Type : | Observational |
Actual Enrollment : | 744 participants |
Observational Model: | Cohort |
Time Perspective: | Retrospective |
Official Title: | Clinical Value of Postoperative C-reactive Protein in the Detection of Complications After Open and Laparoscopic Appendectomy |
Actual Study Start Date : | August 1, 2016 |
Actual Primary Completion Date : | October 30, 2016 |
Actual Study Completion Date : | November 30, 2016 |

Group/Cohort |
---|
open appendectomy
Patients were selected retrospectively on the basis of the documented MEL code (medical service code) of open appendectomy (AE)
|
laparoscopic appendectomy
Patients were selected retrospectively on the basis of the documented MEL code (medical service code) of open laparoscopic appendectomy (LSK AE)
|
- superficial wound infection [ Time Frame: 4 weeks postoperative ]superficial wound infection in open and laparoscopic appendectomy
- intraabdominal abscess [ Time Frame: 4 weeks postoperative ]intraabdominal abscess in open and laparoscopic appendectomy
- ileus [ Time Frame: 4 weeks postoperative ]ileus in open and laparoscopic appendectomy

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 96 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- clinically suspected appendicitis between 1 January 2011 and 31 December 2015
Exclusion Criteria:
- an elective appendectomy as part of an oncological or gynecological operation tumor was found intraoperatively and required ileocecal resection or right hemicolectomy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03119740
Austria | |
Clinic for General and Visceral Surgery, Kepler University Clinic Linz | |
Linz, Upper Austria, Austria, 4020 |
Study Director: | Andreas Shamiyeh, MD | Clinic for General and Visceral Surgery, Kepler University Clinic Linz |
Responsible Party: | Klugsberger Bettina, MD, Ludwig Boltzmann Institute for Operative Laparoscopy |
ClinicalTrials.gov Identifier: | NCT03119740 |
Other Study ID Numbers: |
APPCO-017 |
First Posted: | April 19, 2017 Key Record Dates |
Last Update Posted: | April 19, 2017 |
Last Verified: | April 2017 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Appendicitis Intraabdominal Infections Infection Gastroenteritis |
Gastrointestinal Diseases Digestive System Diseases Cecal Diseases Intestinal Diseases |